脆弱性和类风湿性疾病:迄今为止的证据和经验教训
Sarah B Lieber1, Katherine D Wysham2, Sebastian E Sattui3
1Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, New York, NY, USA; Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
The Lancet. Rheumatology
|November 14, 2024
概括
虚弱,一种减少储备的状态,在免疫媒介性风湿性疾病的早期发生,增加健康风险. 了解脆弱机制和评估可以指导干预措施,以改善患者的结果.
科学领域:
- 类风湿病学 类风湿病学
- 老年学是一门学科.
- 免疫学 免疫学 免疫学
背景情况:
- 虚弱是一种减少生理储备的状态,增加了对不良健康结果的脆弱性.
- 在免疫媒介性类风湿性疾病 (IMRDs) 的成年人中,早发性脆弱性很普遍.
- 脆弱性是IMRDs中不良结果的新兴风险因素.
研究的目的:
- 提供IMRDs中的脆弱性的概念概述.
- 讨论IMRDs的患病率,机制和脆弱性的测量.
- 探索脆弱性评估对临床护理的影响及其与炎症和疾病活动的关系.
主要方法:
- 对现有关于脆弱性的文献进行概念性审查.
- 讨论将脆弱性与IMRDs联系在一起的假定机制.
- 探索脆弱性测量工具及其临床相关性.
主要成果:
- 脆弱性是IMRDs的一个重要问题,影响患者的脆弱性.
- 在IMRD中,关联脆弱性,炎症和疾病活动的机制是复杂的.
- 脆弱性评估具有指导临床护理和干预的潜力.
结论:
- 虚弱是IMRD患者健康的关键因素.
- 对脆弱性流行病学和机制的进一步研究可能使有针对性的干预措施成为可能.
- 针对脆弱性的干预措施可以补充现有疗法,改善生活质量.
相关概念视频
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
7
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
7
Rheumatic Heart Disease I: Introduction
3
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
3
Rheumatic Heart Disease III: Medical Management
3
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3
Rheumatic Heart Disease IV: Nursing Management
5
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
5
Endocarditis II: Clinical features and Diagnostic Tests
2
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
2
Genome-wide Association Studies-GWAS
12.5K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.5K


